Recently,Medtronic Announces New Vice President of Commercial Operations for Surgical Division in China: Laura Zang, Current Assistant Vice President of Boston Scientific and Head of the Cardiac Intervention Business.

Laura's career began at Lingfeng Pharmaceutical, starting as a representative, then moving to Jiangsu.Kangyuan Pharmaceutical, Xi'an Janssen, Bayer and other pharmaceutical factories. Before serving as the IC business leader at Boston Scientific, he also held positions as the business leader and marketing leader for the urology and pelvic health business, as well as the peripheral intervention and oncology business. He is a model example of a frontline professional manager who has advanced through the ranks.

During her tenure as the IC head of Boston Scientific, Laura formulated a differentiated strategy for the company's interventional cardiology business to address various challenges.VBP, DRG/DIP and other external environments, optimized the product portfolio, accelerated the release of localized products, developed various business models, established platform empowerment, and strengthenedChannel StrategyCollaboration, etc., to enhance the headquarters' confidence in the China region.

Laura holds a Bachelor of Pharmacy and a Master of Medical Biochemistry from Beijing University of Chinese Medicine, and she also earned an EMBA degree from CEIBS.

According to reports,Laura will officially join Medtronic on January 30, reporting directly to the Vice President of Medtronic.Jing Yu, General Manager of Medtronic China's Orthopedics and Neurosurgery Business and Surgical Business, joins the Global Surgical Leadership Team and the Greater China Executive Committee.

At the same time, rumors suggest that Laura's successor is about to be confirmed and may be a rather special candidate.